 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | PAK ↓ ↑ | PAK1 ↓ ↑ | PAK2 ↓ ↑ | PAK3 ↓ ↑ | PAK4 ↓ ↑ | PAK5 ↓ ↑ | PAK6 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPA-3 | + PAK1, IC50: 2.5 μM | + PAK1, IC50: 2.5 μM | 99%+ | ||||||||||||||||
| FRAX486 | +++ PAK1, IC50: 14 nM PAK4, IC50: 39 nM | +++ PAK1, IC50: 14 nM | ++ PAK2, IC50: 33 nM | ++ PAK3, IC50: 39 nM | + PAK4, IC50: 575 nM | 99%+ | |||||||||||||
| FRAX1036 | ++ PAK4, Ki: 23.3 nM PAK2, Ki: 72.4 nM | ++ PAK1, Ki: 23.3 nM | ++ PAK2, Ki: 72.4 nM | + PAK4, Ki: 2.4 μM | 99%+ | ||||||||||||||
| FRAX597 | ++++ PAK2, IC50: 13 nM PAK3, IC50: 13 nM | ++++ PAK1, IC50: 8 nM | ++++ PAK2, IC50: 13 nM | +++ PAK3, IC50: 19 nM | 98+% | ||||||||||||||
| PF-3758309 | ++++ PAK6, Ki: 17.1 nM PAK3, IC50: 190 nM | ++++ PAK1, Ki: 13.7 nM | + PAK2, IC50: 190 nM | ++ PAK3, IC50: 99 nM | +++ PAK4, Ki: 18.7 nM | +++ PAK5, Ki: 18.1 nM | +++ PAK6, Ki: 17.1 nM | 99%+ | |||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | G-5555 is a selective PAK1 inhibitor (Ki=3.7 nM). | 
| Concentration | Treated Time | Description | References | |
| THJ-16T | 2.60 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| FTC133 | >10 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 had minimal effect on FTC133 cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| K1 | 6.98 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| 8505C | 6.64 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| SW1736 | 1.37 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| HTh74 | 3.36 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| BCPAP | 2.46 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| TPC1 | 0.50 μM | 72 hours | To evaluate the effect of G-5555 on thyroid cancer cell viability, results showed that G-5555 significantly reduced cell viability | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| CMK cells | 0.03, 0.1, 1, 3, 9, 20μmol/L | 48 hours | Inhibited CMK cell proliferation, 0.03 and 1μmol/L G5555 significantly inhibited CMK cell proliferation; 3μmol/L G5555 had a weaker inhibitory effect on CMK cell cycle; induced apoptosis, 3μmol/L G5555 increased the apoptosis rate of CMK cells by 2%. | Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):499-505 | 
| CHRF cells | 0.03, 0.1, 1, 3, 9, 20μmol/L | 48 hours | Inhibited CHRF cell proliferation, 0.03 and 1μmol/L G5555 significantly inhibited CHRF cell proliferation; 3μmol/L G5555 reduced the percentage of CHRF cells in S phase from 37% to 15%; induced apoptosis, 3μmol/L G5555 increased the apoptosis rate of CHRF cells by 6.5%. | Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):499-505 | 
| Madin-Darby canine kidney epithelial cells | 10 μM | 60 minutes | Measure compound permeability | ACS Med Chem Lett. 2015 Oct 31;6(12):1241-6 | 
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Thyroid-specific inducible BRAFV600E overexpression mouse model | Oral gavage | 25 mg/kg | Twice daily for a week | To evaluate the effect of G-5555 on BRAFV600E-induced thyroid cancer, results showed that G-5555 significantly restrained thyroid size and reduced carcinoma formation | Endocr Relat Cancer. 2019 Aug;26(8):699-712 | 
| Nude mice | H292 NSCLC xenograft model | Oral | 10, 20, 30 mg/kg | Single dose, tumors and blood collected 6 hours postdose | Study the effect of drug dose and exposure on pharmacodynamic biomarker pMEK S298 | ACS Med Chem Lett. 2015 Oct 31;6(12):1241-6 | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.03mL 0.41mL 0.20mL | 10.14mL 2.03mL 1.01mL | 20.29mL 4.06mL 2.03mL | |
| CAS号 | 1648863-90-4 | 
| 分子式 | C25H25ClN6O3 | 
| 分子量 | 492.96 | 
| SMILES Code | ClC(C=C(C1=NC(C)=CC=C1)C=C2)=C2C3=CC4=CN=C(NC)N=C4N(C[C@@H]5OC[C@@H](N)CO5)C3=O | 
| MDL No. | MFCD28506227 | 
| 别名 | |
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C | 
| 溶解方案 | DMSO: 25 mg/mL(50.71 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1